Related Experiment Videos
Abstract:
Biologic response modifiers have expanded the therapeutic horizon of medical oncology. These agents, procedures, and interventions are likely to become an established fourth modality of cancer therapy in the near future. This is a succinct review of the most prominent areas of clinical research and the results obtained, including cytokines (interferons, interleukins), growth factors, monoclonal antibodies, adoptive immunotherapy, and tumor vaccines.
Insights
Biologic response modifiers are emerging as a fourth pillar of cancer therapy. This review covers key research areas like cytokines, growth factors, and immunotherapy, highlighting their therapeutic potential in oncology.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Biologic response modifiers represent a significant advancement in cancer treatment.
- These agents are poised to become a major therapeutic modality alongside surgery, radiation, and chemotherapy.
Purpose of the Study:
- To review prominent areas of clinical research in biologic response modifiers.
- To summarize the obtained results from these investigations.
Main Methods:
- Review of clinical research findings.
- Analysis of data on cytokines (interferons, interleukins), growth factors, monoclonal antibodies, adoptive immunotherapy, and tumor vaccines.
Main Results:
- Biologic response modifiers have demonstrated significant therapeutic potential.
- Key areas of research show promising results in various cancer types.
Conclusions:
- Biologic response modifiers are expanding the therapeutic options in medical oncology.
- These innovative approaches are likely to be integrated as a standard fourth-line cancer treatment.